Beruflich Dokumente
Kultur Dokumente
Diptheria
Preparation
- Combined DPT - Diphtheria Toxoid - Diphther-Tetanus (DT)
Adverse Reactions
- High fever - Collapse followed by either recovery or shock like state of prostration - Thrombocytopenic purpura - Neurologic symptoms: common
Contraindications
- Severe febrile reaction - Any CNS symptom following perussis immunization
Pertussis
Tetanus
Polio
- Tetanus toxid, aluminum adsorbed - DPT - Td - DT: not available in the Philippines - DPT-Polio-HIV - TdAP - Salk vaccine or Inactivated/Killed Polio Vaccine (IPV)
- Local reactions: redness, tenderness, swelling - Systemic: Fever (100-102 F), crying, irritability - Uncommon: persistent crying, high pitched cry, convulsions, hypotonic episodes - Hypersensitivity reaction Rare, usually local erythema/tenderness
- IM
Advantages: - No risk of contracting the disease - Simplicity of storage - Can be given to susceptible adults Disadvantages: - Wild polio virus can still grow in the GIT - Expensive - Reduction of antibody titer - IM injection inconvenient Advantages: - Limits growth of virus in GIT - Ease of administration - Cheap
- Altered immune status and immunosuppressive therapy - Siblings of children who are immunosuppressed - Pregnancy
- any age but must be atleast 3kg optimumly 6mos - EPI: Newborn to 12 mos, right deltoid, 0.5 mL, ID - 0.5 mL, IM or SC, ideally 15 mos. old - during outbreak immunize at 6 mos, then reimmunize at 9-15 mos - post-exposure immunization: within 3 days post-exposure Older children and adults: 0.5 mL, deltoid, IM Infants (<6 mos.): Anterolateral thigh
Disadvantages: - May cause polio in immunosuppressed - Freezing storage temp. inconvenient - No assurance that patient received the vaccine - Local reactions occur within 3-5 weeks. If papule appears early within days, then suspect TB (papule, lymphadenitis, osteomyelitis) - Systemic: minimal or slight, disseminated BCG in immunocompromised Mild - 10-20% low grade fever, malaise, skin rash 510days after - CNS: rare, encephalitis, Reye syndrome, cranial nerve palsy, Guillain-Barre syndrome - SSPE subacute sclerosing panencephalitis: rare
- Generalized malignancies - Skin infections - Immunosuppression - Burns - Prematurity - Severe malnutrition - Allergy to chicken or eggs - Immune deficiency states - Pregnancy - Recent injection of gamma globulin, whole blood derivatives or plasma
Hepatitis B
Rubella
Single dose, SC
- Transient joint manifestations (related to age of vaccine): arthralgia or arthritis 2-10 weeks after - Transient peripheral neuritis
- Jeryl-Lynn Strain: live attenuated growth in chick embryo - Human Diploid cell vaccine Newest formulations: - Purified vercell rabies vaccine: less expensive - PCEC (Chiron) purified chicken: pre-exposure (3 doses at 0, 7, 21,0r 28 days); post exposure (5 doses at 0, 3, 7, 14, 28 days) Japanese Oka Strain
- Single dose, 0.5 mL, SC - Part of MMR 0, 3, 7, 14, 28 days after contact with rabid animal
- Pregnancy - Active PTB - Hypersensitivity to vaccine components (neomycin in package label) - Other general contraindications - General contraindications - Hypersensitivity to neomycin - Pregnancy is NOT a contraindication
Varicella
- SC, 9 mos- 12 yrs old with a recommended 2nd dose prefereably 1 year after
- post exposure: 3-5 days after exposure, otherwise give acyclovir 80mg/kg/day in divided doses for 7 days
transfusion given 3 mos previously conditions associated with sever or fatal varicella: - immune deficiency states (prematurity, cancer, radiotherapy, burns, malnutrition etc) - pregnancy
Influenze Type B
PRP (polyribose ribitol phosphate capsule) Conjugated vaccines: - PRP-D (Prohibit): with Diphtheria Toxoid - PRP-T: Tetanus toxoid - HbOc: CRM (a diptheria toxin) - PRP-OMP: outer membrane protein complex of N. meningitis - Oral vaccine Live attenuated Salmonella typhi type 21 strain Injectible vaccines Vi capsular polysaccharide vaccine
<6 mos: 2,3,4 or 2,4,6 mos >6 mos: 6,7 or 6,8 mos booster: after 1 year
Shigellosis
- Not usually used because not that effective - Claimed to be effective for 3 years
Single dose, SC/IM, effective for 3 years 2-3 weeks after administration Minimum age: 1 y/o
Mild side effects - Local pain - Fever No serious adverse effects reported
- Mild GIT disturbance - <6 y/o or >10 y/o - pregnancy - progressive diseases - general contraindications - Hypersensitivity to vaccine components - Pregnancy - Fever - Severe infection
IM, 2 doses 6-12 mos apart Miminum age: 1 year old - Cheaper, given 2 years old and above - 2,4,6,12 mos
Influenza Vaccine
Meningococcus
Meningococcal polysaccharide vaccine (against group A and C): Type B is deadly but its not that infectious Prepared as duck embryo or human diploid cell culture
SC as single dose